Effects of blockade of central dopamine D1 and D2 receptors on thermoregulation, metabolic rate and running performance

Abstract

To assess the effects of a blockade of central D1- and D2-dopaminergic receptors on metabolic rate, heat balance and running performance, 10nmol (2μl) of a solution of the D1 antagonist SCH-23390 hydrochloride (SCH,n= 6), D2 antagonist eticlopride hydrochloride (Eti, n=6), or 2μl of 0.15 MNaCl (SAL, n=6) was injected intracerebroventricularly into Wistar rats before the animals began graded running until fatigue (starting at i0m/min, increasing by 1m/min increment every 3min until fatigue, 5% inclination). Oxygen consumption and body temperature were recorded at rest, during exercise and following 30min of recovery. Control experiments with injection of two doses (10 and 20nmol/rat) of either SCH or Eti solution were carried out in resting rats as well. Body heating rate, heat storage, workload and mechanical efficiency were calculated. Although SCH and Eti treatments did not induce thermal effects in resting animals, they markedly reduced running performance (–83%, SCH; -59% Eti, p<0.05) and decreased maximal oxygen uptake (–79%, SCH; -45%, Eti, p<0.05) in running rats. In addition, these treatments induced a higher body heating rate and persistent hyperthermia during the recovery period. Our data demonstrate that the alteration in dopamine transmission induced by the central blockade of dopamine- D1 and D2 receptors impairs running performance by decreasing the tolerance to heat storage. This blockade also impairs the dissipation of exercise-induced heat and metabolic rate recovery during the post-exercise period. Our results provide evidence that central activation of either dopamine- Di or D2 receptors is essential for heat balance and exercise performance.